InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 repr…
